Literature DB >> 25171156

Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy.

Elisabetta Parretta1, Concetta Rafaniello, Lara Magro, Anna Coggiola Pittoni, Liberata Sportiello, Carmen Ferrajolo, Annamaria Mascolo, Maurizio Sessa, Francesco Rossi, Annalisa Capuano.   

Abstract

OBJECTIVE: Adverse drug reaction (ADR) reporting by patients has a fundamental role in pharmacovigilance. The main objectives of the present study were to assess the impact of a pharmacist-based intervention in promoting direct patient reporting, to evaluate patient ability to identify and report ADRs and to determine their pattern. RESEARCH DESIGN AND METHODS: The study involved 96 pharmacists in the Campania region of Italy, who interviewed their customers and asked them whether they had experienced an ADR. Patients who had experienced an ADR were invited to complete an ADR reporting form. The quality of completed ADR reporting forms was evaluated before their entry into the Italian Spontaneous Reporting System (Rete Nazionale di Farmacovigilanza [RNF]) and, once entered, their pattern was determined.
RESULTS: A total of 18,677 patients were interviewed, and 10.88% had experienced an ADR. After quality control, 54.32% of all reporting forms were entered into the RNF so that patient contribution to spontaneous reporting, null over the years, reached ∼7%. Patients reported mainly non-serious (91.28%) and expected (94.62%) ADRs, and NSAIDs or antibiotics were the most frequently reported drugs.
CONCLUSIONS: The study shows that pharmacists can have an important role in promoting patient reporting and adds new information on how a patient reporting form should be structured.

Entities:  

Keywords:  direct patient reporting; pharmacist; pharmacovigilance; spontaneous reporting

Mesh:

Year:  2014        PMID: 25171156     DOI: 10.1517/14740338.2014.939582

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  12 in total

Review 1.  ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

Authors:  Linda Härmark; Florence van Hunsel; Birgitta Grundmark
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

2.  Current trends in pharmacovigilance: value and gaps of patient reporting.

Authors:  Pedro Inácio; Afonso Cavaco; Marja Airaksinen
Journal:  Int J Clin Pharm       Date:  2018-07-13

3.  Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers.

Authors:  Amira S A Said; Nadia Hussain
Journal:  Hosp Pharm       Date:  2017-05-01

4.  Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.

Authors:  Cristiano Matos; Linda Härmark; Florence van Hunsel
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

Review 5.  Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System.

Authors:  Paola Maria Cutroneo; Claudia Giardina; Valentina Ientile; Simona Potenza; Laura Sottosanti; Carmen Ferrajolo; Costantino J Trombetta; Gianluca Trifirò
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

6.  The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.

Authors:  Leàn Rolfes; Florence van Hunsel; Laura van der Linden; Katja Taxis; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2017-07       Impact factor: 5.606

7.  Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions.

Authors:  Maurizio Sessa; Liberata Sportiello; Annamaria Mascolo; Cristina Scavone; Silvia Gallipoli; Gabriella di Mauro; Daniela Cimmaruta; Concetta Rafaniello; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2017-05-26       Impact factor: 5.810

Review 8.  Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review.

Authors:  Maurizio Sessa; Claudia Rossi; Annamaria Mascolo; Cristina Scavone; Gabriella di Mauro; Roberto Grassi; Liberata Sportiello; Salvatore Cappabianca; Concetta Rafaniello
Journal:  Ther Clin Risk Manag       Date:  2017-10-24       Impact factor: 2.423

9.  Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors.

Authors:  Maurizio Sessa; Gabriella di Mauro; Annamaria Mascolo; Concetta Rafaniello; Liberata Sportiello; Cristina Scavone; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2018-06-12       Impact factor: 5.810

10.  Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study.

Authors:  Maurizio Sessa; Annamaria Mascolo; Cristina Scavone; Ilaria Perone; Annalisa Di Giorgio; Michele Tari; Annamaria Fucile; Antonella De Angelis; Daniel Bech Rasmussen; Magnus Thorsten Jensen; Kristian Kragholm; Francesco Rossi; Annalisa Capuano; Liberata Sportiello
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.